FOR the 6,000 people in the UK who are newly diagnosed with bile duct cancer every year, the prognosis is uniquely grim.

Ric Hartig says weight lifting helped him overcome a lifetime of health issues: rheumatoid arthritis, ulcers, shoulder ...

Doctors in the UK are hoping to transform the lives of people with deadly bile duct cancer. A new study – which has shown ...

A new clinical trial, sponsored by UCL and UCLH, aims to extend survival for some patients with cancer in the biliary tract by treating them with ...

CBX-12 is under clinical development by Cybrexa and currently in Phase II for Gallbladder Cancer. According to GlobalData, Phase II drugs for Gallbladder Cancer have a 32% phase transition success ...

SGPGI Lucknow developed a new treatment regimen combining chemotherapy and radiotherapy for gallbladder cancer. Led by Professor Sushma Agrawal, the five-year study revealed improved life expectancy ...

The surgeon general’s report said the lifetime risk of developing any alcohol-related cancer jumped to 19 percent (19 of 100 ...

A U.K. woman, who was diagnosed with a rare cancer, recalls having eight organs removed in what she described as 'the mother ...

Pfizer chief oncology officer Roger Dansey said: “The initial therapy of high-risk, non-muscle invasive bladder cancer with BCG has not advanced in decades. Today’s pivotal Phase III CREST ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

The SGPGI Lucknow has developed a new treatment regimen for gallbladder cancer patients, which could nearly double their life expectancy while costing a fraction of the expensive immunotherapy, ...

led a five-year study examining the effects of altering conventional chemotherapy by adding radiotherapy in 140 patients with localised gallbladder cancer who were not suitable for surgical ...